|1.||Zhang, Yi: 1 article (02/2010)|
|2.||Chen, Xiaoguang: 1 article (02/2010)|
|3.||Li, Hongyan: 1 article (02/2010)|
|4.||Zheng, Xuguang: 1 article (02/2010)|
|5.||Wang, Hongbo: 1 article (02/2010)|
|6.||Xin, Hongqi: 1 article (02/2010)|
|1.||Diabetic Nephropathies (Diabetic Nephropathy)
02/10/2010 - "The streptozotocin-induced diabetic rats were used to investigate the beneficial effects of XLF-III-43 treatment on diabetic nephropathy. "
02/10/2010 - "The purpose of this study was to examine the novel coumarin-aspirin compound XLF-III-43 in the inhibition of AGE formation in diabetic nephropathy. "
02/10/2010 - "XLF-III-43, a novel coumarin-aspirin compound, prevents diabetic nephropathy in rats via inhibiting advanced glycation end products."
|1.||Aspirin (Acetylsalicylic Acid)
|3.||Advanced Glycosylation End Products